Peter Bouwman
Impact in
- Oncology top 1%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Molecular Biology top 2%
- DNA Repair Mechanisms
- Sphingolipid Metabolism and Signaling
- Genomics and Chromatin Dynamics
Papers in
- Co-authors
- Jos Jonkers (21 shared papers)Sjaak Philipsen (4 shared papers)Mark Pieterse (4 shared papers)Madalena Tarsounas (5 shared papers)Sven Rottenberg (4 shared papers)Christine L. Mummery (2 shared papers)José Miguel Escandell (3 shared papers)Maria Thanasoula (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)The Journal of Pathology (3 papers)Cancer Research (3 papers)Nature Structural & Molecular Biology (2 papers)Cancer Discovery (2 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Peter Bouwman
49 papers receiving 5.6k citations
Peter Bouwman's Hit Papers
Peers
Comparison fields: 5 of 99
- Oncology 1.7k
- Molecular Biology 2.8k
- Cancer Research 393
- Genetics 644
- Immunology 201
Countries citing papers authored by Peter Bouwman
This map shows the geographic impact of Peter Bouwman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bouwman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bouwman more than expected).
Fields of papers citing papers by Peter Bouwman
This network shows the impact of papers produced by Peter Bouwman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bouwman. The network helps show where Peter Bouwman may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Bouwman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers Hit paper breakdown → | 2010 | 813 |
| 2 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 579 |
| 3 | 2012 | 535 | |
| 4 | REV7 counteracts DNA double-strand break resection and affects PARP inhibition Hit paper breakdown → | 2015 | 505 |
| 5 | 2006 | 471 | |
| 6 | 2002 | 397 | |
| 7 | 2013 | 245 | |
| 8 | 2016 | 231 | |
| 9 | 2011 | 224 | |
| 10 | 2000 | 164 | |
| 11 | 2004 | 138 | |
| 12 | 2010 | 135 | |
| 13 | 2013 | 135 | |
| 14 | 2016 | 118 | |
| 15 | 2013 | 110 | |
| 16 | 2017 | 89 | |
| 17 | 1994 | 74 | |
| 18 | 2009 | 69 | |
| 19 | 2017 | 63 | |
| 20 | 2001 | 51 |
About Peter Bouwman
Peter Bouwman is a scholar working on Genetics, Oncology, Molecular Biology, Cancer Research and Pharmacology, having authored 50 papers that have together received 5.7k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (14 papers), DNA Repair Mechanisms (10 papers), PARP inhibition in cancer therapy (10 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Telomeres, Telomerase, and Senescence (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), Usability and User Interface Design (2 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). The work is most often cited by research in Oncology (1.7k citations), Molecular Biology (2.8k citations), Cancer Research (393 citations), Genetics (644 citations) and Immunology (201 citations). Peter Bouwman has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Jos Jonkers, Sjaak Philipsen, Mark Pieterse, Madalena Tarsounas, Sven Rottenberg, Christine L. Mummery, José Miguel Escandell, Maria Thanasoula, David J. Adams and Shridar Ganesan. Their work appears in journals such as Clinical Cancer Research, The Journal of Pathology, Cancer Research, Nature Structural & Molecular Biology and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.